CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Glaxo Smithkline Consumer Nigeria PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Glaxo Smithkline Consumer Nigeria PLC
1 Industrial Avenue, Ilupeju
Phone: +234 12711000p:+234 12711000 LAGOS, Nigeria Fax: +234 12716172f:+234 12716172
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
GlaxoSmithKline Consumer Nigeria Plc is a Nigeria-based healthcare company. The principal activities of the Company are marketing and distribution of consumer healthcare and pharmaceutical products. The Company is engaged in the marketing and distribution of a range of healthcare brands in Nigeria. The Company’s segments include Consumer Healthcare and Pharmaceutical. The Consumer Healthcare segment consists of oral care and over the counter (OTC) medicines. The Pharmaceuticals segment consists of antibiotics, vaccines and prescription drugs. The Company offers Consumer Healthcare brands, such as Panadol, Sensodyne, Andrews Liver Salt and Macleans and a range of internationally acclaimed pharmaceuticals, including Augmentin, Ampiclox and Amoxil (antibiotics); Zentel (the anthelmintic), and vaccines. It also provides a range of prescription medicines, vaccines and consumer healthcare products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2844 Perfumes, cosmetics, and other toilet preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman Edmund C.Onuzo 6/12/2014 6/1/2006
Managing Director, Executive Director KunleOyelana 6/1/2019 6/1/2019
Finance Director, Executive Director BoscoKirugi 6/1/2019 6/1/2019
12 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 1,195,876,000 (As of 9/30/2023)
Shareholders: 27,337
Stock Exchange: NIG
Fax Number: +234 12716172


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024